• Fractional non-ablative aesthetic laser module from Lumenis receives FDA approval

    Medical laser maker Lumenis has received FDA clearance for its ResurFX fractional non-ablative laser module.
    Sept. 16, 2013

    Medical laser maker Lumenis (Yokneam, Israel) has received FDA clearance for its ResurFX fractional non-ablative laser module. ResurFX is an application module for the company's M22 platform, expanding its capabilities to perform fractional non-ablative skin resurfacing, a fast-growing, minimally invasive procedure.

    Related: Lumenis debuts fractional non-ablative laser module for common skin disorders

    ResurFX uses a 1565 nm fiber laser and the company's CoolScan scanner technology, which enables a homogeneous, uniform pattern of coagulation columns in one pass to help protect the patient's skin, the company claims. The scanner also allows a choice between more than 600 combinations of shape, size, and density, A proprietary algorithm places each fractional spot in a controlled, non-sequential manner, allowing the tissue to relax between pulses and providing protection from overheating.

    ResurFX will be one of of the company's products featured at the 5-Continent Congress (5CC), which will take place from September 18-21, 2013, in Cannes, France.

    -----

    Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

    Subscribe now to BioOptics World magazine; it's free!

    Sign up for Laser Focus World Newsletters
    Get the latest news and updates.

    Voice Your Opinion!

    To join the conversation, and become an exclusive member of Laser Focus World, create an account today!